Labor And Delivery is an indication for drug development with over 10 pipeline drugs currently active. According to GlobalData, preregistered drugs for Labor And Delivery have a 66.67% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Labor And Delivery compared to historical benchmarks. Buy the report here.

Smarter leaders trust GlobalData

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Labor And Delivery overview

Labor and delivery encompass the final stages of pregnancy, where the culmination of the gestation period results in childbirth. Labor marks the onset of uterine contractions, initiating the process of the cervix dilating and the baby descending through the birth canal. Delivery, or childbirth, occurs when the baby is expelled from the mother’s uterus into the external environment. This dynamic process involves various stages, from the initial contractions to the actual birth, with healthcare professionals closely monitoring the well-being of both the mother and the newborn. Medical interventions may be employed to ensure a safe and healthy delivery experience.

For a complete picture of PTSR and LoA scores for drugs in Labor And Delivery, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.